bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy, Symtuza)
Jump to navigation
Jump to search
Introduction
Both Biktarvy & Symtuza contain tenofovir alafenamide
Indications
- treatment of HIV1 infection to achieve undetectable HIV1 RNA viral load
Dosage
- bictegravir/emtricitabine/tenofovir AF
- tablet: 50mg/200mg/25mg
- 1 tablet PO QD
More general terms
Components
References
- ↑ PubChem: 129626368
- ↑ RxNorm
- ↑ Medscape: bictegravir/emtricitabine/tenofovir AF (Rx) https://reference.medscape.com/drug/biktarvy-bictegravir-emtricitabine-tenofovir-af-1000199